Gingivitis Market Report 2026

Gingivitis Market Report 2026
Global Outlook – By Treatment Type (Medication, Surgical Procedures, Non-Surgical Treatments), By Route Of Administration (Oral, Topical ), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By End-User (Hospitals, Dental Clinics, Homecare Settings) - Market Size, Trends, And Global Forecast 2026-2035
Gingivitis Market Overview
• Gingivitis market size has reached to $7.45 billion in 2025 • Expected to grow to $9.3 billion in 2030 at a compound annual growth rate (CAGR) of 4.5% • Growth Driver: Increasing Prevalence Of Gum Disease Fueling The Growth Of The Market Due To Rising Cases And Unhealthy Lifestyle Factors • Market Trend: Rise Of Formulated Toothpaste Driving Innovation In The Market • North America was the largest region in 2025.What Is Covered Under Gingivitis Market?
Gingivitis is a common and mild form of gum disease (periodontal disease) characterized by inflammation, redness, swelling, and bleeding of the gums, primarily caused by plaque buildup along the gumline. If left untreated, it can progress to more severe periodontal diseases, potentially leading to gum recession and tooth loss. The main treatment types of gingivitis are medication, surgical procedures, and non-surgical treatments. Medications for gingivitis include antimicrobial mouthwashes, antiseptic gels, and antibiotic treatments that help reduce inflammation, control bacterial growth, and promote gum healing. Various routes of administration include oral and topical and are distributed through retail pharmacies, hospital pharmacies, and online pharmacies. End-users include hospitals, dental clinics, and homecare settings.
What Is The Gingivitis Market Size and Share 2026?
The gingivitis market size has grown steadily in recent years. It will grow from $7.45 billion in 2025 to $7.8 billion in 2026 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to poor oral hygiene habits, growth in dental consultations, early adoption of antiseptic treatments, public health dental programs, rising sugar consumption.What Is The Gingivitis Market Growth Forecast?
The gingivitis market size is expected to see steady growth in the next few years. It will grow to $9.3 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to preventive dentistry adoption, expansion of oral care products, digital dental consultations, school-based oral health programs, rising healthcare literacy. Major trends in the forecast period include increased focus on preventive oral care, rising use of non-surgical treatments, growth in antibacterial oral care products, expansion of home-based oral hygiene solutions, improved public awareness of gum health.Global Gingivitis Market Segmentation
1) By Treatment Type: Medication, Surgical Procedures, Non-Surgical Treatments 2) By Route Of Administration: Oral, Topical 3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies 4) By End-User: Hospitals, Dental Clinics, Homecare Settings Subsegments: 1) By Medication: Antibiotics, Antiseptic Mouthwashes, Anti-Inflammatory Drugs, Pain Relievers 2) By Surgical Procedures: Flap Surgery, Gingivectomy, Gingivoplasty, Laser Therapy 3) By Non-Surgical Treatments: Scaling and Root Planing, Professional Dental Cleaning, Local Drug Delivery, Lifestyle and Dietary ModificationsWhat Is The Driver Of The Gingivitis Market?
The increasing prevalence of gum disease is expected to propel the growth of the gingivitis market going forward. Gum disease is a prevalent oral condition involving inflammation, infection, or deterioration of the gums and surrounding tissues, primarily due to plaque accumulation and inadequate oral care. The rising prevalence of gum disease is primarily due to poor oral hygiene, leading to plaque buildup and bacterial infections. Unhealthy diets high in sugar and processed foods contribute to gum inflammation, while smoking weakens the immune response, making gums more susceptible to infection. Gingivitis, as the earliest stage of gum disease, significantly contributes to its increasing prevalence by serving as a gateway to more severe conditions such as periodontitis when left untreated, highlighting the need for early intervention and preventive care. For instance, in January 2024, according to a report published by the Office for Health Improvement & Disparities (OHID), a UK-based government body, the percentage of adults diagnosed with gum disease increased from 4% among those aged 16–24 to 28% among individuals aged 55–64, emphasizing a higher prevalence with age. Therefore, the increasing prevalence of gum disease is driving the growth of the gingivitis industry.Key Players In The Global Gingivitis Market
Major companies operating in the gingivitis market are Procter & Gamble, Colgate-Palmolive Company, Haleon group, Bausch Health Companies Inc., Kivonyx Healthcare Pvt Ltd., ICPA Health Products Limited, Alarsin Pharmaceuticals, Laboratorios KIN, Ikon remedies pvt ltd., Perio Protect LLC, Algen Healthcare Ltd, Neuracle Lifesciences Private Limited, Dental Herb Company, Shreeji Pharma International, Pfizer Inc., Johnson & Johnson, 3M Company, Dentsply Sirona Inc., Sunstar Group, GC Corporation, Ivoclar Vivadent AG, Straumann Group, Ultradent Products Inc, Nobel Biocare Holdings AGGlobal Gingivitis Market Trends and Insights
Major companies operating in the gingivitis market are developing innovative products such as formulated toothpaste to effectively target gum inflammation, reduce plaque buildup, and promote overall oral health. Formulated toothpaste is a specially designed toothpaste with specific active ingredients to address targeted oral health concerns such as cavities, gingivitis, or sensitivity. For instance, in February 2023, Frimline Private Limited, an India-based healthcare and personal care company, introduced Dente91 She toothpaste. This innovative toothpaste is formulated with lactoferrin, a potent antimicrobial protein that protects against oral infections and inflammation. Unlike conventional toothpaste, Dente91 She is specially enriched with folic acid (vitamin B9) and pyridoxine (vitamin B6) to support women's oral health through various hormonal changes, from puberty to menopause.What Are Latest Mergers And Acquisitions In The Gingivitis Market?
In October 2024, Natural Dentist LLC, a US-based oral care company, acquired Caldwell Consumer Products, including The Natural Dentist, Stim-U-Dent, Fresh ‘n Brite, and EarthPicks, for an undisclosed amount. This acquisition aims to expand Natural Dentist LLC’s product portfolio, enhance its supply chain efficiency, and drive innovation in holistic oral care solutions. Caldwell Consumer Health LLC is a US-based consumer healthcare company specializing in oral care and personal health products.Regional Outlook
North America was the largest region in the gingivitis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Gingivitis Market?
The gingivitis market consists of revenues earned by entities providing services such as preventive dental care, periodontal therapy, and laser therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gingivitis market also includes sales of toothpaste, mouthwashes, and interdental brushes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Gingivitis Market Report 2026?
The gingivitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gingivitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Gingivitis Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.8 billion |
| Revenue Forecast In 2035 | $9.3 billion |
| Growth Rate | CAGR of 4.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Treatment Type, Route Of Administration, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Procter & Gamble, Colgate-Palmolive Company, Haleon group, Bausch Health Companies Inc., Kivonyx Healthcare Pvt Ltd., ICPA Health Products Limited, Alarsin Pharmaceuticals, Laboratorios KIN, Ikon remedies pvt ltd., Perio Protect LLC, Algen Healthcare Ltd, Neuracle Lifesciences Private Limited, Dental Herb Company, Shreeji Pharma International, Pfizer Inc., Johnson & Johnson, 3M Company, Dentsply Sirona Inc., Sunstar Group, GC Corporation, Ivoclar Vivadent AG, Straumann Group, Ultradent Products Inc, Nobel Biocare Holdings AG |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Gingivitis market was valued at $7.45 billion in 2025, increased to $7.8 billion in 2026, and is projected to reach $9.3 billion by 2030.
request a sample hereThe global Gingivitis market is expected to grow at a CAGR of 4.5% from 2026 to 2035 to reach $9.3 billion by 2035.
request a sample hereSome Key Players in the Gingivitis market Include, Procter & Gamble, Colgate-Palmolive Company, Haleon group, Bausch Health Companies Inc., Kivonyx Healthcare Pvt Ltd., ICPA Health Products Limited, Alarsin Pharmaceuticals, Laboratorios KIN, Ikon remedies pvt ltd., Perio Protect LLC, Algen Healthcare Ltd, Neuracle Lifesciences Private Limited, Dental Herb Company, Shreeji Pharma International, Pfizer Inc., Johnson & Johnson, 3M Company, Dentsply Sirona Inc., Sunstar Group, GC Corporation, Ivoclar Vivadent AG, Straumann Group, Ultradent Products Inc, Nobel Biocare Holdings AG .
request a sample hereMajor trend in this market includes: Rise Of Formulated Toothpaste Driving Innovation In The Market. For further insights on this market.
request a sample hereNorth America was the largest region in the gingivitis market in 2025. The regions covered in the gingivitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here